567 related articles for article (PubMed ID: 12731455)
1. Selective mitochondrial KATP channel activation by nicorandil and 3-pyridyl pinacidil results in antiarrhythmic effect in an anesthetized rabbit model of myocardial ischemia/reperfusion.
Das B; Sarkar C
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):97-110. PubMed ID: 12731455
[TBL] [Abstract][Full Text] [Related]
2. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Das B; Sarkar C
Pharmacol Res; 2003 Jun; 47(6):447-61. PubMed ID: 12741997
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model.
Das B; Sarkar C
Pol J Pharmacol; 2003; 55(5):771-86. PubMed ID: 14704474
[TBL] [Abstract][Full Text] [Related]
5. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
[TBL] [Abstract][Full Text] [Related]
6. Selective mitochondrial K(ATP) channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Eur J Pharmacol; 2002 Feb; 437(3):165-71. PubMed ID: 11890905
[TBL] [Abstract][Full Text] [Related]
7. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
8. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
Gonca E; Bozdogan O
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):403-11. PubMed ID: 20693159
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts.
Tsai CH; Su SF; Chou TF; Lee TM
J Pharmacol Exp Ther; 2002 Apr; 301(1):234-40. PubMed ID: 11907179
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: potentiation of ischaemic preconditioning via KATP channels.
Nakae I; Takaoka A; Mitsunami K; Yabe T; Ito M; Masayuki ; Takahashi ; Matsumoto T; Omura T; Yokohama H; Kinoshita M
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):810-7. PubMed ID: 11022974
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
Fryer RM; Hsu AK; Nagase H; Gross GJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):451-7. PubMed ID: 10900218
[TBL] [Abstract][Full Text] [Related]
12. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S; Baczkó I; Leprán I
Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
[TBL] [Abstract][Full Text] [Related]
13. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning.
Ghosh S; Standen NB; Galiñanes M
Cardiovasc Res; 2000 Mar; 45(4):934-40. PubMed ID: 10728419
[TBL] [Abstract][Full Text] [Related]
14. Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels.
Tanno M; Miura T; Tsuchida A; Miki T; Nishino Y; Ohnuma Y; Shimamoto K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):226-32. PubMed ID: 11521165
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.
Das B; Sarkar C; Shankar PR
Cardiovasc Drugs Ther; 2007 Aug; 21(4):243-51. PubMed ID: 17520332
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive delayed limb ischemic preconditioning attenuates myocardial ischemia-reperfusion injury in rats by a mitochondrial K(ATP) channel-dependent mechanism.
Wu YN; Yu H; Zhu XH; Yuan HJ; Kang Y; Jiao JJ; Gao WZ; Liu YX; Lou JS
Physiol Res; 2011; 60(2):271-9. PubMed ID: 21114361
[TBL] [Abstract][Full Text] [Related]
17. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
Fischbach PS; White A; Barrett TD; Lucchesi BR
J Pharmacol Exp Ther; 2004 May; 309(2):554-9. PubMed ID: 14747611
[TBL] [Abstract][Full Text] [Related]
18. Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat.
Kita H; Miura T; Tsuchida A; Hasegawa T; Shimamoto K
J Cardiovasc Pharmacol; 1998 Nov; 32(5):791-7. PubMed ID: 9821854
[TBL] [Abstract][Full Text] [Related]
19. Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.
Hide EJ; Ney P; Piper J; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2435-40. PubMed ID: 8581281
[TBL] [Abstract][Full Text] [Related]
20. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
